Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness

Journal of Allergy and Clinical Immunology

Volumn 140, Issue 4, 2017, Pages 909-920

  Edwards, Michael R ^a,b   Strong, Katherine ^a,b   Cameron, Aoife ^a,b   Walton, Ross P ^a,b   Jackson, David J ^a,b,c   Johnston, Sebastian L ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

allergic inflammation; asthma; interferon; TH2; Virus

Indexed keywords

BIOLOGICAL PRODUCT; INTERFERON; MESSENGER RNA;

ALLERGIC ASTHMA; ASTHMA; DISEASE ASSOCIATION; DISEASE EXACERBATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; INTERFERON PRODUCTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY VIRUS; REVIEW; SENSITIZATION; TH2 CELL; VIRAL RESPIRATORY TRACT INFECTION; ANIMAL; DISEASE COURSE; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; METABOLISM; RESPIRATORY TRACT INFECTION; TRENDS; VIRUS INFECTION;

ALLERGY AND IMMUNOLOGY; ANIMALS; DISEASE PROGRESSION; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INTERFERONS; RESPIRATORY TRACT INFECTIONS; TH2 CELLS; VIRUS DISEASES;

EID: 85031856879     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.07.025     Document Type: Review

References (96)

1. Edwards, M.R., Bartlett, N.W., Hussell, T., Openshaw, P., Johnston, S.L., The microbiology of asthma. Nat Rev Microbiol 10 (2012), 459–471.
2. Jackson, D.J., Makrinioti, H., Rana, B.M., Shamji, B.W., Trujillo-Torralbo, M.B., Footitt, J., et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 190 (2014), 1373–1382.
3. Beale, J., Jayaraman, A., Jackson, D.J., Macintyre, J.D., Edwards, M.R., Walton, R.P., et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med, 6, 2014, 256ra134.
4. Bufe, A., Gehlhar, K., Grage-Griebenow, E., Ernst, M., Atopic phenotype in children is associated with decreased virus-induced interferon-alpha release. Int Arch Allergy Immunol 127 (2002), 82–88.
5. Wark, P.A., Johnston, S.L., Bucchieri, F., Powell, R., Puddicombe, S., Laza-Stanca, V., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201 (2005), 937–947.
6. Contoli, M., Message, S.D., Laza-Stanca, V., Edwards, M.R., Wark, P.A., Bartlett, N.W., et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12 (2006), 1023–1026.
7. Message, S.D., Laza-Stanca, V., Mallia, P., Parker, H.L., Zhu, J., Kebadze, T., et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A 105 (2008), 13562–13567.
8. Johnston, N.W., Johnston, S.L., Duncan, J.M., Greene, J.M., Kebadze, T., Keith, P.K., et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 115 (2005), 132–138.
9. Johnston, S.L., Pattemore, P.K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310 (1995), 1225–1229.
10. Johnston, S.L., Pattemore, P.K., Sanderson, G., Smith, S., Campbell, M.J., Josephs, L.K., et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 154 (1996), 654–660.
11. Bizzintino, J., Lee, W.M., Laing, I.A., Vang, F., Pappas, T., Zhang, G., et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 37 (2010), 1037–1042.
12. Khetsuriani, N., Kazerouni, N.N., Erdman, D.D., Lu, X., Redd, S.C., Anderson, L.J., et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 119 (2007), 314–321.
13. Arden, K.E., Chang, A.B., Lambert, S.B., Nissen, M.D., Sloots, T.P., Mackay, I.M., Newly identified respiratory viruses in children with asthma exacerbation not requiring admission to hospital. J Med Virol 82 (2010), 1458–1461.
14. Sigurs, N., Bjarnason, R., Sigurbergsson, F., Kjellman, B., Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161 (2000), 1501–1507.
15. Roman, M., Calhoun, W.J., Hinton, K.L., Avendano, L.F., Simon, V., Escobar, A.M., et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 156 (1997), 190–195.
16. Holt, P.G., Sly, P.D., Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 18 (2012), 726–735.
17. Becker, Y., Respiratory syncytial virus(RSV)-induced allergy may be controlled by IL-4 and CX3C fractalkine antagonists and CpG ODN as adjuvant: hypothesis and implications for treatment. Virus Genes 33 (2006), 253–264.
18. Kotenko, S.V., Gallagher, G., Baurin, V.V., Lewis-Antes, A., Shen, M., Shah, N.K., et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4 (2003), 69–77.
19. Isaacs, A., Lindenmann, J., Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147 (1957), 258–267.
20. de Veer, M.J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J.M., et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69 (2001), 912–920.
21. Marcello, T., Grakoui, A., Barba-Spaeth, G., Machlin, E.S., Kotenko, S.V., MacDonald, M.R., et al. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131 (2006), 1887–1898.
22. Bartlett, N.W., Slater, L., Glanville, N., Haas, J.J., Caramori, G., Casolari, P., et al. Defining critical roles for NF-kappaB p65 and type I interferon in innate immunity to rhinovirus. EMBO Mol Med 4 (2012), 1244–1260.
23. Schoggins, J.W., Wilson, S.J., Panis, M., Murphy, M.Y., Jones, C.T., Bieniasz, P., et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472 (2011), 481–485.
24. Slater, L., Bartlett, N.W., Haas, J.J., Zhu, J., Message, S.D., Walton, R.P., et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog, 6, 2010, e1001178.
25. Wang, Q., Miller, D.J., Bowman, E.R., Nagarkar, D.R., Schneider, D., Zhao, Y., et al. MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PLoS Pathog, 7, 2011, e1002070.
26. Wang, Q., Nagarkar, D.R., Bowman, E.R., Schneider, D., Gosangi, B., Lei, J., et al. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol 183 (2009), 6989–6997.
27. Corne, J.M., Marshall, C., Smith, S., Schreiber, J., Sanderson, G., Holgate, S.T., et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359 (2002), 831–834.
28. Gill, M.A., Bajwa, G., George, T.A., Dong, C.C., Dougherty, I.I., Jiang, N., et al. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol 184 (2010), 5999–6006.
29. Durrani, S.R., Montville, D.J., Pratt, A.S., Sahu, S., Devries, M.K., Rajamanickam, V., et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol 130 (2012), 489–495.
30. Sykes, A., Edwards, M.R., Macintyre, J., Del Rosario, A., Bakhsoliani, E., Trujillo-Torralbo, M.B., et al. Rhinovirus 16-induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol 129 (2012), 1506–1514.e6.
31. Rupani, H., Martinez-Nunez, R.T., Dennison, P., Lau, L.C., Jayasekera, N., Havelock, T., et al. Toll-like receptor 7 is reduced in severe asthma and linked to an altered microRNA profile. Am J Respir Crit Care Med 194 (2016), 26–37.
32. Gehlhar, K., Bilitewski, C., Reinitz-Rademacher, K., Rohde, G., Bufe, A., Impaired virus-induced interferon-alpha2 release in adult asthmatic patients. Clin Exp Allergy 36 (2006), 331–337.
33. Kicic, A., Stevens, P.T., Sutanto, E.N., Kicic-Starcevich, E., Ling, K.M., Looi, K., et al. Impaired airway epithelial cell responses from children with asthma to rhinoviral infection. Clin Exp Allergy 46 (2016), 1441–1455.
34. Baraldo, S., Contoli, M., Bazzan, E., Turato, G., Padovani, A., Marku, B., et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol 130 (2012), 1307–1314.
35. Uller, L., Leino, M., Bedke, N., Sammut, D., Green, B., Lau, L., et al. Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma. Thorax 65 (2010), 626–632.
36. Edwards, M.R., Regamey, N., Vareille, M., Kieninger, E., Gupta, A., Shoemark, A., et al. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol 6 (2012), 797–806.
37. Djukanovic, R., Harrison, T., Johnston, S.L., Gabbay, F., Wark, P., Thomson, N.C., et al. The effect of inhaled IFN-beta on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med 190 (2014), 145–154.
38. Bochkov, Y.A., Hanson, K.M., Keles, S., Brockman-Schneider, R.A., Jarjour, N.N., Gern, J.E., Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 3 (2010), 69–80.
39. Lopez-Souza, N., Favoreto, S., Wong, H., Ward, T., Yagi, S., Schnurr, D., et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol 123 (2009), 1384–1390.e2.
40. Patel, D.A., You, Y., Huang, G., Byers, D.E., Kim, H.J., Agapov, E., et al. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. J Allergy Clin Immunol 134 (2014), 1402–1412.e7.
41. Baturcam, E., Snape, N., Yeo, T.H., Schagen, J., Thomas, E., Logan, J., et al. Human metapneumovirus impairs apoptosis of nasal epithelial cells in asthma via HSP70. J Innate Immun 9 (2016), 52–64.
42. Cakebread, J.A., Xu, Y., Grainge, C., Kehagia, V., Howarth, P.H., Holgate, S.T., et al. Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. J Allergy Clin Immunol 127 (2011), 1148–1154.e9.
43. Sykes, A., Macintyre, J., Edwards, M.R., Del Rosario, A., Haas, J., Gielen, V., et al. Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax 69 (2014), 240–246.
44. Wark, P.A., Grissell, T., Davies, B., See, H., Gibson, P.G., Diversity in the bronchial epithelial cell response to infection with different rhinovirus strains. Respirology 14 (2009), 180–186.
45. Spann, K.M., Baturcam, E., Schagen, J., Jones, C., Straub, C.P., Preston, F.M., et al. Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy. Thorax 69 (2014), 918–925.
46. Wagener, A.H., Zwinderman, A.H., Luiten, S., Fokkens, W.J., Bel, E.H., Sterk, P.J., et al. dsRNA-induced changes in gene expression profiles of primary nasal and bronchial epithelial cells from patients with asthma, rhinitis and controls. Respir Res, 15, 2014, 9.
47. Iikura, K., Katsunuma, T., Saika, S., Saito, S., Ichinohe, S., Ida, H., et al. Peripheral blood mononuclear cells from patients with bronchial asthma show impaired innate immune responses to rhinovirus in vitro. Int Arch Allergy Immunol 155:suppl 1 (2011), 27–33.
48. Lin, L., Belgrave, D., Bakhsoliani, E., Hirsman, A., Edwards, M.R., Walton, R.P., et al. Phenotyping immune responses in asthma and respiratory infections. 2016 May 13-18, Proceedings of the American Thoracic Society Conference, San Francisco, A7870.
49. Hatchwell, L., Collison, A., Girkin, J., Parsons, K., Li, J., Zhang, J., et al. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax 70 (2015), 854–861.
50. Collison, A., Hatchwell, L., Verrills, N., Wark, P.A., de Siqueira, A.P., Tooze, M., et al. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med 19 (2013), 232–237.
51. Teach, S.J., Gill, M.A., Togias, A., Sorkness, C.A., Arbes, S.J. Jr., Calatroni, A., et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol 136 (2015), 1476–1485.
52. Globinska, A., Pawelczyk, M., Piechota-Polanczyk, A., Olszewska-Ziaber, A., Moskwa, S., Mikolajczyk, A., et al. Impaired virus replication and decreased innate immune responses to viral infections in nasal epithelial cells from patients with allergic rhinitis. Clin Exp Immunol 187 (2016), 100–112.
53. da Silva, J., Hilzendeger, C., Moermans, C., Schleich, F., Henket, M., Kebadze, T., et al. Raised interferon-beta, type 3 interferon and interferon-stimulated genes—evidence of innate immune activation in neutrophilic asthma. Clin Exp Allergy 47 (2016), 313–323.
54. Bergauer, A., Sopel, N., Kross, B., Vuorinen, T., Xepapadaki, P., Weiss, S.T., et al. IFN-α/IFN-λ responses to respiratory viruses in paediatric asthma. Eur Respir J, 49, 2017.
55. Hansel, T.T., Tunstall, T., Trujillo-Torralbo, M.B., Shamji, B., Del-Rosario, A., Dhariwal, J., et al. A comprehensive evaluation of nasal and bronchial cytokines and chemokines following experimental rhinovirus infection in allergic asthma: increased interferons (IFN-γ and IFN-λ) and type 2 inflammation (IL-5 and IL-13). EBioMedicine 19 (2017), 128–138.
56. Proud, D., Turner, R.B., Winther, B., Wiehler, S., Tiesman, J.P., Reichling, T.D., et al. Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. Am J Respir Crit Care Med 178 (2008), 962–968.
57. Woodruff, P.G., Boushey, H.A., Dolganov, G.M., Barker, C.S., Yang, Y.H., Donnelly, S., et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A 104 (2007), 15858–15863.
58. Choy, D.F., Modrek, B., Abbas, A.R., Kummerfeld, S., Clark, H.F., Wu, L.C., et al. Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. J Immunol 186 (2010), 1861–1869.
59. Moller-Larsen, S., Nyegaard, M., Haagerup, A., Vestbo, J., Kruse, T.A., Borglum, A.D., Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax 63 (2008), 1064–1069.
60. Sharma, V., Michel, S., Gaertner, V., Franke, A., Vogelberg, C., von Berg, A., et al. Fine-mapping of IgE-associated loci 1q23, 5q31, and 12q13 using 1000 Genomes Project data. Allergy 69 (2014), 1077–1084.
61. Moffatt, M.F., Gut, I.G., Demenais, F., Strachan, D.P., Bouzigon, E., Heath, S., et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363 (2010), 1211–1221.
62. Bedke, N., Sammut, D., Green, B., Kehagia, V., Dennison, P., Jenkins, G., et al. Transforming growth factor-Beta promotes rhinovirus replication in bronchial epithelial cells by suppressing the innate immune response. PLoS One, 7, 2012, e44580.
63. Gielen, V., Sykes, A., Zhu, J., Chan, B., Macintyre, J., Regamey, N., et al. Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons. J Allergy Clin Immunol 136 (2015), 177–188.e11.
64. Fukuyama, S., Nakano, T., Matsumoto, T., Oliver, B.G., Burgess, J.K., Moriwaki, A., et al. Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype. Am J Respir Crit Care Med 179 (2009), 992–998.
65. Harada, M., Nakashima, K., Hirota, T., Shimizu, M., Doi, S., Fujita, K., et al. Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma. Am J Respir Cell Mol Biol 36 (2007), 491–496.
66. Pothlichet, J., Chignard, M., Si-Tahar, M., Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J Immunol 180 (2008), 2034–2038.
67. Baetz, A., Koelsche, C., Strebovsky, J., Heeg, K., Dalpke, A.H., Identification of a nuclear localization signal in suppressor of cytokine signaling 1. FASEB J 22 (2008), 4296–4305.
68. Doran, E., Choy, D.F., Shikotra, A., Butler, C.A., O'Rourke, D.M., Johnston, J.A., et al. Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma. Eur Respir J 48 (2016), 715–725.
69. Fahy, J.V., Type 2 inflammation in asthma—present in most, absent in many. Nat Rev Immunol 15 (2014), 57–65.
70. Green, R.M., Custovic, A., Sanderson, G., Hunter, J., Johnston, S.L., Woodcock, A., Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ, 324, 2002, 763.
71. Murray, C.S., Poletti, G., Kebadze, T., Morris, J., Woodcock, A., Johnston, S.L., et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 61 (2006), 376–382.
72. Bartlett, N.W., Walton, R.P., Edwards, M.R., Aniscenko, J., Caramori, G., Zhu, J., et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 14 (2008), 199–204.
73. Sparer, T.E., Matthews, S., Hussell, T., Rae, A.J., Garcia-Barreno, B., Melero, J.A., et al. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J Exp Med 187 (1998), 1921–1926.
74. Tebbey, P.W., Hagen, M., Hancock, G.E., Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J Exp Med 188 (1998), 1967–1972.
75. Schwarze, J., Hamelmann, E., Bradley, K.L., Takeda, K., Gelfand, E.W., Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 100 (1997), 226–233.
76. Green, R.H., Brightling, C.E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 (2002), 1715–1721.
77. Pritchard, A.L., Carroll, M.L., Burel, J.G., White, O.J., Phipps, S., Upham, J.W., Innate IFNs and plasmacytoid dendritic cells constrain Th2 cytokine responses to rhinovirus: a regulatory mechanism with relevance to asthma. J Immunol 188 (2012), 5898–5905.
78. Huber, J.P., Ramos, H.J., Gill, M.A., Farrar, J.D., Cutting edge: type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol 185 (2010), 813–817.
79. Edwards, S., Jones, C., Leishman, A.J., Young, B.W., Matsui, H., Tomizawa, H., et al. TLR7 Stimulation of APCs results in inhibition of IL-5 through type I IFN and Notch signaling pathways in human peripheral blood mononuclear cells. J Immunol 190 (2013), 2585–2592.
80. Subrata, L.S., Bizzintino, J., Mamessier, E., Bosco, A., McKenna, K.L., Wikstrom, M.E., et al. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol 183 (2009), 2793–2800.
81. Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Ubel, C., et al. IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med 3 (2011), 348–361.
82. Duerr, C.U., McCarthy, C.D., Mindt, B.C., Rubio, M., Meli, A.P., Pothlichet, J., et al. Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nat Immunol 17 (2015), 65–75.
83. Lynch, J.P., Werder, R.B., Simpson, J., Loh, Z., Zhang, V., Haque, A., et al. Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. J Allergy Clin Immunol 138 (2016), 1326–1337.
84. Thomas, B.J., Lindsay, M., Dagher, H., Freezer, N.J., Li, D., Ghildyal, R., et al. Transforming growth factor-beta enhances rhinovirus infection by diminishing early innate responses. Am J Respir Cell Mol Biol 41 (2009), 339–347.
85. Contoli, M., Ito, K., Padovani, A., Poletti, D., Marku, B., Edwards, M.R., et al. Th2-cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy 70 (2015), 910–920.
86. Corren, J., Lemanske, R.F., Hanania, N.A., Korenblat, P.E., Parsey, M.V., Arron, J.R., et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 365 (2011), 1088–1098.
87. Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 368 (2013), 2455–2466.
88. Nair, P., Pizzichini, M.M., Kjarsgaard, M., Inman, M.D., Efthimiadis, A., Pizzichini, E., et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 360 (2009), 985–993.
89. Pavord, I.D., Korn, S., Howarth, P., Bleecker, E.R., Buhl, R., Keene, O.N., et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 380 (2012), 651–659.
90. Castro, M., Wenzel, S.E., Bleecker, E.R., Pizzichini, E., Kuna, P., Busse, W.W., et al. Benralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study. Lancet Respir Med 2 (2014), 879–890.
91. Castro, M., Mathur, S., Hargreave, F., Boulet, L.P., Xie, F., Young, J., et al. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 184 (2011), 1125–1132.
92. Wenzel, S., Wilbraham, D., Fuller, R., Getz, E.B., Longphre, M., Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370 (2007), 1422–1431.
93. Pettipher, R., Hunter, M.G., Perkins, C.M., Collins, L.P., Lewis, T., Baillet, M., et al. Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459. Allergy 69 (2014), 1223–1232.
94. Gonem, S., Berair, R., Singapuri, A., Hartley, R., Laurencin, M.F., Bacher, G., et al. Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial. Lancet Respir Med 4 (2016), 699–707.
95. Krug, N., Hohlfeld, J.M., Kirsten, A.M., Kornmann, O., Beeh, K.M., Kappeler, D., et al. Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. N Engl J Med 372 (2015), 1987–1995.
96. Busse, W.W., Morgan, W.J., Gergen, P.J., Mitchell, H.E., Gern, J.E., Liu, A.H., et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 364 (2011), 1005–1015.